Myeloproliferative Neoplasms (mpns) - Histology

Relevant Publications

Overview of dyslipidemia and metabolic syndrome in myeloproliferative neoplasms.

Issue Release: 2024

Dysmorphic megakaryocytes in TAFRO syndrome: A case series from a single institute.

Issue Release: 2024

Neutrophil-specific expression of JAK2-V617F or CALRmut induces distinct inflammatory profiles in myeloproliferative neoplasia.

Issue Release: 2024

Assessment of Total Antioxidant Capacity, 8-Hydroxy-2\'-deoxy-guanosine, the Genetic Landscape, and Their Associations in -Negative Chronic and Blast Phase Myeloproliferative Neoplasms.

Issue Release: 2024

ADAMTS13, von Willebrand Factor, Platelet Microparticles, Factor VIII, and Impact of Somatic Mutations in the Pathogenesis of Splanchnic Vein Thrombosis Associated with BCR-ABL-Negative Myeloproliferative Neoplasms.

Issue Release: 2024

Functional and Structural Characterization of Clinical-Stage Janus Kinase 2 Inhibitors Identifies Determinants for Drug Selectivity.

Issue Release: 2024

Associations of the circulating levels of cytokines with the risk of myeloproliferative neoplasms: a bidirectional mendelian-randomization study.

Issue Release: 2024

Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms.

Issue Release: 2024

Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights.

Issue Release: 2024

CXCL8 and its cognate receptors CXCR1/CXCR2 in primary myelofibrosis.

Issue Release: 2024

[Analysis of CHIP-Related Mutation and Risk of Cardio-Cerebrovasculars Events in Patients with Myeloproliferative Neoplasms].

Issue Release: 2024

Interferons in the treatment of myeloproliferative neoplasms.

Issue Release: 2024

Recombinant interferon alfa in BCR/ABL-negative chronic myeloproliferative neoplasms.

Issue Release: 2024

Lysosomal Degradation Targets Mutant Calreticulin and the Thrombopoietin Receptor in Myeloproliferative Neoplasms.

Issue Release: 2024

Percutaneous mesocaval shunt creation for portal thrombosis in a patient with a JAK2V617F mutation.

Issue Release: 2024

Chronic myeloproliferative neoplasms with concomitant mutation and translocation: diagnostic and therapeutic implications of a rare hybrid disease.

Issue Release: 2024

Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan.

Issue Release: 2024

DARS expression in BCR/ABL1-negative myeloproliferative neoplasms and its association with the immune microenvironment.

Issue Release: 2024

Liver and spleen shear-wave elastography in the diagnosis and severity staging of myeloproliferative diseases and myelofibrosis.

Issue Release: 2024

Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis.

Issue Release: 2024

What Does the Certification Exam Entail?

Why is Histological Staining Important?

What is the Future of EHRs in Histology?

What are the Applications of Microscopic Evaluation?

How is Honeycombing Identified?

What are the Challenges in Forensic Histology?

What are the Therapeutic Implications of Targeting CD47?

What Happens After IRB Approval?

What are Chronic Lung Diseases?

How to Maintain Microscope Quality?

Partnered Content Networks

Relevant Topics